Major changes to type 2 diabetes treatment could save thousands of lives | National Institute for Health and Clinical Excellence (NICE)
New guidance means millions of people will get access to medicines that protect the heart and kidneys, while NHS savings of £560 million from using generic dapagliflozin can be reinvested elsewhere in NHS care. Millions of people with type 2 diabetes could live longer, healthier lives under new NICE recommendations that put individual needs at … Read more